nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Progesterone—uterine cancer	0.151	0.236	CbGbCtD
Cyclobenzaprine—CYP2D6—Progesterone—uterine cancer	0.124	0.195	CbGbCtD
Cyclobenzaprine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.119	0.187	CbGbCtD
Cyclobenzaprine—CYP3A4—Progesterone—uterine cancer	0.079	0.124	CbGbCtD
Cyclobenzaprine—CYP1A2—Etoposide—uterine cancer	0.0675	0.106	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—uterine cancer	0.0379	0.0594	CbGbCtD
Cyclobenzaprine—CYP3A4—Etoposide—uterine cancer	0.0354	0.0554	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—uterine cancer	0.0241	0.0378	CbGbCtD
Cyclobenzaprine—Stomatitis—Etoposide—uterine cancer	0.000783	0.00217	CcSEcCtD
Cyclobenzaprine—Jaundice—Etoposide—uterine cancer	0.000783	0.00217	CcSEcCtD
Cyclobenzaprine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000782	0.00217	CcSEcCtD
Cyclobenzaprine—Malaise—Dactinomycin—uterine cancer	0.000782	0.00217	CcSEcCtD
Cyclobenzaprine—Leukopenia—Dactinomycin—uterine cancer	0.000776	0.00215	CcSEcCtD
Cyclobenzaprine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000776	0.00215	CcSEcCtD
Cyclobenzaprine—Atrioventricular block—Doxorubicin—uterine cancer	0.000768	0.00213	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Doxorubicin—uterine cancer	0.000763	0.00211	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Doxorubicin—uterine cancer	0.000758	0.0021	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Etoposide—uterine cancer	0.000749	0.00208	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00207	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000742	0.00205	CcSEcCtD
Cyclobenzaprine—Myalgia—Dactinomycin—uterine cancer	0.000738	0.00204	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Progesterone—uterine cancer	0.000738	0.00204	CcSEcCtD
Cyclobenzaprine—Discomfort—Dactinomycin—uterine cancer	0.000729	0.00202	CcSEcCtD
Cyclobenzaprine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.002	CcSEcCtD
Cyclobenzaprine—Asthenia—Progesterone—uterine cancer	0.000718	0.00199	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Etoposide—uterine cancer	0.000717	0.00199	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00199	CcSEcCtD
Cyclobenzaprine—Pruritus—Progesterone—uterine cancer	0.000708	0.00196	CcSEcCtD
Cyclobenzaprine—Oedema—Dactinomycin—uterine cancer	0.000708	0.00196	CcSEcCtD
Cyclobenzaprine—Hypertonia—Epirubicin—uterine cancer	0.000705	0.00195	CcSEcCtD
Cyclobenzaprine—Mental disability—Epirubicin—uterine cancer	0.000698	0.00193	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000693	0.00192	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Progesterone—uterine cancer	0.000685	0.0019	CcSEcCtD
Cyclobenzaprine—Anorexia—Dactinomycin—uterine cancer	0.000675	0.00187	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00185	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Epirubicin—uterine cancer	0.000668	0.00185	CcSEcCtD
Cyclobenzaprine—Dizziness—Progesterone—uterine cancer	0.000662	0.00183	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Epirubicin—uterine cancer	0.000653	0.00181	CcSEcCtD
Cyclobenzaprine—Hypertonia—Doxorubicin—uterine cancer	0.000653	0.00181	CcSEcCtD
Cyclobenzaprine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.0018	CcSEcCtD
Cyclobenzaprine—Mental disability—Doxorubicin—uterine cancer	0.000646	0.00179	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000645	0.00179	CcSEcCtD
Cyclobenzaprine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00178	CcSEcCtD
Cyclobenzaprine—Alopecia—Etoposide—uterine cancer	0.000637	0.00176	CcSEcCtD
Cyclobenzaprine—Vomiting—Progesterone—uterine cancer	0.000637	0.00176	CcSEcCtD
Cyclobenzaprine—Rash—Progesterone—uterine cancer	0.000631	0.00175	CcSEcCtD
Cyclobenzaprine—Dermatitis—Progesterone—uterine cancer	0.000631	0.00175	CcSEcCtD
Cyclobenzaprine—Headache—Progesterone—uterine cancer	0.000627	0.00174	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000621	0.00172	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000618	0.00171	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dactinomycin—uterine cancer	0.000615	0.0017	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Etoposide—uterine cancer	0.000615	0.0017	CcSEcCtD
Cyclobenzaprine—Fatigue—Dactinomycin—uterine cancer	0.00061	0.00169	CcSEcCtD
Cyclobenzaprine—Purpura—Epirubicin—uterine cancer	0.000606	0.00168	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Doxorubicin—uterine cancer	0.000604	0.00167	CcSEcCtD
Cyclobenzaprine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0006	0.00166	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000596	0.00165	CcSEcCtD
Cyclobenzaprine—Nausea—Progesterone—uterine cancer	0.000595	0.00165	CcSEcCtD
Cyclobenzaprine—Diplopia—Epirubicin—uterine cancer	0.000584	0.00162	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Epirubicin—uterine cancer	0.000584	0.00162	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dactinomycin—uterine cancer	0.000583	0.00161	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Etoposide—uterine cancer	0.000582	0.00161	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000579	0.0016	CcSEcCtD
Cyclobenzaprine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000577	0.0016	CcSEcCtD
Cyclobenzaprine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000572	0.00158	CcSEcCtD
Cyclobenzaprine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000571	0.00158	CcSEcCtD
Cyclobenzaprine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.00157	CcSEcCtD
Cyclobenzaprine—Malaise—Etoposide—uterine cancer	0.000566	0.00157	CcSEcCtD
Cyclobenzaprine—Face oedema—Epirubicin—uterine cancer	0.000564	0.00156	CcSEcCtD
Cyclobenzaprine—Vertigo—Etoposide—uterine cancer	0.000564	0.00156	CcSEcCtD
Cyclobenzaprine—Leukopenia—Etoposide—uterine cancer	0.000562	0.00156	CcSEcCtD
Cyclobenzaprine—Purpura—Doxorubicin—uterine cancer	0.000561	0.00155	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dactinomycin—uterine cancer	0.000559	0.00155	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Etoposide—uterine cancer	0.000552	0.00153	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000552	0.00153	CcSEcCtD
Cyclobenzaprine—Ataxia—Epirubicin—uterine cancer	0.000549	0.00152	CcSEcCtD
Cyclobenzaprine—Convulsion—Etoposide—uterine cancer	0.000544	0.00151	CcSEcCtD
Cyclobenzaprine—Hypertension—Etoposide—uterine cancer	0.000542	0.0015	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—uterine cancer	0.00054	0.0015	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—uterine cancer	0.00054	0.0015	CcSEcCtD
Cyclobenzaprine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00149	CcSEcCtD
Cyclobenzaprine—Chest pain—Etoposide—uterine cancer	0.000534	0.00148	CcSEcCtD
Cyclobenzaprine—Discomfort—Etoposide—uterine cancer	0.000528	0.00146	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—uterine cancer	0.000522	0.00144	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—uterine cancer	0.000521	0.00144	CcSEcCtD
Cyclobenzaprine—Gastritis—Epirubicin—uterine cancer	0.000517	0.00143	CcSEcCtD
Cyclobenzaprine—Confusional state—Etoposide—uterine cancer	0.000516	0.00143	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Etoposide—uterine cancer	0.000512	0.00142	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—uterine cancer	0.000508	0.00141	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—uterine cancer	0.000508	0.00141	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Etoposide—uterine cancer	0.000501	0.00139	CcSEcCtD
Cyclobenzaprine—Tachycardia—Etoposide—uterine cancer	0.0005	0.00138	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Epirubicin—uterine cancer	0.0005	0.00138	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Etoposide—uterine cancer	0.000495	0.00137	CcSEcCtD
Cyclobenzaprine—Anorexia—Etoposide—uterine cancer	0.000488	0.00135	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—uterine cancer	0.000484	0.00134	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Epirubicin—uterine cancer	0.000479	0.00133	CcSEcCtD
Cyclobenzaprine—Hypotension—Etoposide—uterine cancer	0.000479	0.00133	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—uterine cancer	0.000478	0.00132	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000469	0.0013	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Epirubicin—uterine cancer	0.000466	0.00129	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—uterine cancer	0.000462	0.00128	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etoposide—uterine cancer	0.00046	0.00127	CcSEcCtD
Cyclobenzaprine—Weight increased—Epirubicin—uterine cancer	0.000459	0.00127	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Etoposide—uterine cancer	0.000457	0.00126	CcSEcCtD
Cyclobenzaprine—Somnolence—Etoposide—uterine cancer	0.000455	0.00126	CcSEcCtD
Cyclobenzaprine—Drowsiness—Epirubicin—uterine cancer	0.00045	0.00125	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—uterine cancer	0.00045	0.00125	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—uterine cancer	0.000446	0.00124	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Etoposide—uterine cancer	0.000445	0.00123	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—uterine cancer	0.000444	0.00123	CcSEcCtD
Cyclobenzaprine—Fatigue—Etoposide—uterine cancer	0.000442	0.00122	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000441	0.00122	CcSEcCtD
Cyclobenzaprine—Stomatitis—Epirubicin—uterine cancer	0.000439	0.00122	CcSEcCtD
Cyclobenzaprine—Jaundice—Epirubicin—uterine cancer	0.000439	0.00122	CcSEcCtD
Cyclobenzaprine—Constipation—Etoposide—uterine cancer	0.000438	0.00121	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000434	0.0012	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—uterine cancer	0.000432	0.0012	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—uterine cancer	0.000432	0.0012	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—uterine cancer	0.000425	0.00118	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etoposide—uterine cancer	0.000422	0.00117	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—uterine cancer	0.00042	0.00116	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—uterine cancer	0.00042	0.00116	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etoposide—uterine cancer	0.000419	0.00116	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—uterine cancer	0.000416	0.00115	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000408	0.00113	CcSEcCtD
Cyclobenzaprine—Urticaria—Etoposide—uterine cancer	0.000407	0.00113	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—uterine cancer	0.000406	0.00112	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—uterine cancer	0.000406	0.00112	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etoposide—uterine cancer	0.000405	0.00112	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—uterine cancer	0.000404	0.00112	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—uterine cancer	0.000402	0.00111	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—uterine cancer	0.000401	0.00111	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—uterine cancer	0.000399	0.00111	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—uterine cancer	0.000389	0.00108	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etoposide—uterine cancer	0.000377	0.00104	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—uterine cancer	0.000377	0.00104	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—uterine cancer	0.000374	0.00104	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000372	0.00103	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—uterine cancer	0.000371	0.00103	CcSEcCtD
Cyclobenzaprine—Asthenia—Etoposide—uterine cancer	0.000367	0.00102	CcSEcCtD
Cyclobenzaprine—Pruritus—Etoposide—uterine cancer	0.000362	0.001	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—uterine cancer	0.000361	0.001	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—uterine cancer	0.000357	0.000989	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR2—uterine cancer	0.000357	0.438	CrCbGaD
Cyclobenzaprine—Diarrhoea—Etoposide—uterine cancer	0.00035	0.00097	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—uterine cancer	0.000349	0.000965	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—uterine cancer	0.000347	0.00096	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—uterine cancer	0.000345	0.000956	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—uterine cancer	0.000344	0.000954	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—uterine cancer	0.000342	0.000946	CcSEcCtD
Cyclobenzaprine—Dizziness—Etoposide—uterine cancer	0.000339	0.000938	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—uterine cancer	0.000334	0.000925	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—uterine cancer	0.000332	0.000918	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—uterine cancer	0.00033	0.000915	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—uterine cancer	0.000326	0.000904	CcSEcCtD
Cyclobenzaprine—Vomiting—Etoposide—uterine cancer	0.000326	0.000902	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—uterine cancer	0.000323	0.000895	CcSEcCtD
Cyclobenzaprine—Rash—Etoposide—uterine cancer	0.000323	0.000894	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etoposide—uterine cancer	0.000323	0.000893	CcSEcCtD
Cyclobenzaprine—Headache—Etoposide—uterine cancer	0.000321	0.000889	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—uterine cancer	0.000321	0.000888	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—uterine cancer	0.000319	0.000885	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—uterine cancer	0.000319	0.000883	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—uterine cancer	0.000317	0.000878	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—uterine cancer	0.000316	0.000875	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—uterine cancer	0.000316	0.000875	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—uterine cancer	0.000315	0.000874	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—uterine cancer	0.000315	0.000872	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—uterine cancer	0.000311	0.000861	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—uterine cancer	0.000309	0.000856	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—uterine cancer	0.000307	0.000849	CcSEcCtD
Cyclobenzaprine—Convulsion—Epirubicin—uterine cancer	0.000305	0.000844	CcSEcCtD
Cyclobenzaprine—Nausea—Etoposide—uterine cancer	0.000304	0.000842	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—uterine cancer	0.000304	0.000841	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000302	0.000836	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—uterine cancer	0.000299	0.000829	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—uterine cancer	0.000299	0.000829	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—uterine cancer	0.000299	0.000828	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—uterine cancer	0.000298	0.000826	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—uterine cancer	0.000296	0.000819	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—uterine cancer	0.000294	0.000813	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—uterine cancer	0.000293	0.000811	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—uterine cancer	0.000292	0.00081	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—uterine cancer	0.000292	0.000808	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—uterine cancer	0.000291	0.000807	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—uterine cancer	0.000289	0.000802	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—uterine cancer	0.000288	0.000797	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—uterine cancer	0.000287	0.000795	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—uterine cancer	0.000287	0.000795	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—uterine cancer	0.000286	0.000792	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—uterine cancer	0.000282	0.000782	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—uterine cancer	0.000282	0.000781	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—uterine cancer	0.000281	0.000778	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—uterine cancer	0.000281	0.000778	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—uterine cancer	0.00028	0.000776	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—uterine cancer	0.000278	0.000769	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—uterine cancer	0.000277	0.000767	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—uterine cancer	0.000277	0.000767	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—uterine cancer	0.000276	0.000765	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—uterine cancer	0.000274	0.000758	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—uterine cancer	0.000274	0.000758	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—uterine cancer	0.000271	0.00075	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—uterine cancer	0.000268	0.000743	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—uterine cancer	0.000268	0.000742	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—uterine cancer	0.000266	0.000736	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000266	0.000736	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000262	0.000724	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—uterine cancer	0.000261	0.000724	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—uterine cancer	0.00026	0.00072	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—uterine cancer	0.00026	0.000719	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—uterine cancer	0.000259	0.000718	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—uterine cancer	0.000258	0.000714	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000257	0.000711	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—uterine cancer	0.000256	0.000709	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—uterine cancer	0.000255	0.000707	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—uterine cancer	0.000253	0.000701	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—uterine cancer	0.000253	0.0007	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—uterine cancer	0.00025	0.000691	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—uterine cancer	0.000248	0.000687	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—uterine cancer	0.000248	0.000685	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—uterine cancer	0.000246	0.00068	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000242	0.00067	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—uterine cancer	0.00024	0.000665	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP19A1—uterine cancer	0.000239	0.293	CrCbGaD
Cyclobenzaprine—Paraesthesia—Doxorubicin—uterine cancer	0.000239	0.000661	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—uterine cancer	0.000237	0.000656	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—uterine cancer	0.000237	0.000655	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—uterine cancer	0.000236	0.000654	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000235	0.00065	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—uterine cancer	0.000234	0.000648	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—uterine cancer	0.000231	0.000639	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—uterine cancer	0.000229	0.000634	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—uterine cancer	0.000228	0.000632	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—uterine cancer	0.000227	0.000629	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—uterine cancer	0.000227	0.000628	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR1—uterine cancer	0.00022	0.27	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—uterine cancer	0.000219	0.000606	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000217	0.000602	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—uterine cancer	0.000212	0.000586	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—uterine cancer	0.000211	0.000584	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—uterine cancer	0.00021	0.000582	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—uterine cancer	0.000206	0.00057	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—uterine cancer	0.000203	0.000562	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Epirubicin—uterine cancer	0.000196	0.000544	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—uterine cancer	0.000196	0.000542	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—uterine cancer	0.000191	0.000528	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—uterine cancer	0.00019	0.000526	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—uterine cancer	0.000188	0.00052	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—uterine cancer	0.000183	0.000506	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—uterine cancer	0.000182	0.000503	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—uterine cancer	0.000181	0.000501	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—uterine cancer	0.000181	0.000501	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—uterine cancer	0.00018	0.000498	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—uterine cancer	0.000176	0.000486	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—uterine cancer	0.000171	0.000472	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—uterine cancer	0.000169	0.000468	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—uterine cancer	0.000167	0.000464	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—uterine cancer	0.000167	0.000463	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—uterine cancer	0.000166	0.000461	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—uterine cancer	0.000158	0.000437	CcSEcCtD
